Journal de la sclérose en plaques

Impact of fingolimod on multiple sclerosis

Gowthami Bainaboina

The effectiveness of fingolimod on clinical and magnetic resonance imaging (MRI) outcomes in patients with multiple sclerosis (MS) has been well established in trials and, to a lesser extent, in the real world